<p>Replimune Group Inc., a clinical stage biotechnology company focused on developing novel oncolytic immunotherapies, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2025, at 1:30 PM PT. A simultaneous webcast of the presentation will be available on the Investors section of the company’s website, with a replay accessible for 30 days following the event. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Replimune Group Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9604168-en) on December 18, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

REPL

<p>Replimune Group Inc., a biotechnology company, will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2025. The presentation will be webcast live on the company's website, with a replay available for 30 days. This announcement was originally published by Replimune Group via GlobeNewswire.</p>

Replimune Group to Present at J.P. Morgan Healthcare Conference